Comparing two medicines to prevent dizziness in vestibular migraine
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study compares two oral medications—rimegepant and flunarizine—to see how well they prevent dizzy or vertigo episodes in people with vestibular migraine. You will take one of the two medicines daily for several months, and track your symptoms on a smartphone app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You need to have had at least 5 episodes of dizziness or vertigo (spinning or rocking feeling) lasting from 5 minutes to 3 days, and also have migraines (with or without aura).
- During the 4-week check-in period, you need to have at least 4 days with moderate or severe dizziness or vertigo.
- You must be able to use a smartphone app to record your symptoms daily and have access to email.
- You cannot have other inner ear conditions (like Meniere's disease), have had ear surgery (other than ear tubes), or have used certain migraine prevention drugs (CGRP blockers or flunarizine) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.
This study tests a medication called rimegepant to see if it quickly relieves vertigo and dizziness during a vestibular migraine attack. Vestibular migraine causes symptoms like spinning or imbalance, often with headache. If you have frequent, moderate-to-severe episodes, this treatment might offer relief.
This study will track how current treatments work for adults with vestibular migraine, a condition where migraine causes dizziness and balance problems. It may help doctors learn which options help most in everyday life.
This study tests whether two types of migraine prevention medicines—standard preventive therapies versus newer anti-CGRP treatments—can help reduce tinnitus (ringing or buzzing in the ears) in people who also have migraines. If you have both conditions, this trial may help find a treatment that eases your ear symptoms.
This study tests a new questionnaire designed to measure how vestibular migraine (a type of migraine that causes dizziness) affects daily life in teenagers. Participating may help improve how doctors evaluate and support young people with this condition.
This study tests a medication called rimegepant (a CGRP blocker) as a treatment for sudden dizziness attacks that come with migraine-like symptoms. If you have these kinds of dizzy spells, this trial may help find out if the drug can stop them quickly.
Hear when a new Vestibular Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.